117 related articles for article (PubMed ID: 26857856)
1. Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.
Abe H; Wada H; Baghdadi M; Nakanishi S; Usui Y; Tsuchikawa T; Shichinohe T; Hirano S; Seino K
Hum Cell; 2016 Apr; 29(2):58-66. PubMed ID: 26857856
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines.
Ravindranathan S; Nguyen KG; Kurtz SL; Frazier HN; Smith SG; Koppolu BP; Rajaram N; Zaharoff DA
Breast Cancer Res; 2018 Oct; 20(1):126. PubMed ID: 30348199
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
4. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
Vendrell A; Gravisaco MJ; Pasetti MF; Croci M; Colombo L; Rodríguez C; Mongini C; Waldner CI
Vaccine; 2011 Jan; 29(4):728-36. PubMed ID: 21095252
[TBL] [Abstract][Full Text] [Related]
5. Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer.
Wang WQ; Zhao D; Zhou YS; Hu XY; Sun ZN; Yu G; Wu WT; Chen S; Kuang JL; Xu GG; Han ZC; Wang BM; Yang JX; Feng XM
Acta Pharmacol Sin; 2015 Apr; 36(4):528-34. PubMed ID: 25832432
[TBL] [Abstract][Full Text] [Related]
6. Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases.
Lewis JD; Shearer MH; Kennedy RC; Bright RK
Cancer Res; 2005 Apr; 65(7):2938-46. PubMed ID: 15805297
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with IFN-inducible T cell alpha chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells.
Yang X; Chu Y; Wang Y; Guo Q; Xiong S
Vaccine; 2006 Apr; 24(15):2966-74. PubMed ID: 16503368
[TBL] [Abstract][Full Text] [Related]
8. Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2.
Yan HX; Cheng P; Wei HY; Shen GB; Fu LX; Ni J; Wu Y; Wei YQ
Oncol Rep; 2013 Apr; 29(4):1510-6. PubMed ID: 23404510
[TBL] [Abstract][Full Text] [Related]
9. Eps8 vaccine exerts prophylactic antitumor effects in a murine model: a novel vaccine for breast carcinoma.
He YJ; Zhou J; Zhao TF; Hu LS; Gan JY; Deng L; Li Y
Mol Med Rep; 2013 Aug; 8(2):662-8. PubMed ID: 23754615
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model.
Urueña C; Gomez A; Sandoval T; Hernandez J; Li S; Barreto A; Fiorentino S
Integr Cancer Ther; 2015 Sep; 14(5):468-83. PubMed ID: 26220604
[TBL] [Abstract][Full Text] [Related]
11. A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer.
Geng F; Guo J; Guo QQ; Xie Y; Dong L; Zhou Y; Liu CL; Yu B; Wu H; Wu JX; Zhang HH; Kong W; Yu XH
Vaccine; 2019 Jul; 37(31):4382-4391. PubMed ID: 31202521
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine.
Huang X; Ye D; Thorpe PE
Vaccine; 2011 Jun; 29(29-30):4785-93. PubMed ID: 21557977
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine.
Lin TJ; Liang WM; Hsiao PW; M S P; Wei WC; Lin HT; Yin SY; Yang NS
PLoS One; 2015; 10(10):e0138335. PubMed ID: 26426423
[TBL] [Abstract][Full Text] [Related]
14. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.
Chandra D; Quispe-Tintaya W; Jahangir A; Asafu-Adjei D; Ramos I; Sintim HO; Zhou J; Hayakawa Y; Karaolis DK; Gravekamp C
Cancer Immunol Res; 2014 Sep; 2(9):901-10. PubMed ID: 24913717
[TBL] [Abstract][Full Text] [Related]
15. Immunogene therapy.
Lichtor T; Glick RP
Adv Exp Med Biol; 2012; 746():151-65. PubMed ID: 22639166
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
17. Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
Guo W; Jia L; Xie L; Kiang JG; Wang Y; Sun F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S; Wang X
Cell Death Dis; 2024 Apr; 15(4):298. PubMed ID: 38678042
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.
Yin SY; Efferth T; Jian FY; Chen YH; Liu CI; Wang AH; Chen YR; Hsiao PW; Yang NS
Oncotarget; 2016 Jul; 7(28):43629-43653. PubMed ID: 27248319
[TBL] [Abstract][Full Text] [Related]
19. Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation.
Chen L; Huang TG; Meseck M; Mandeli J; Fallon J; Woo SL
Mol Ther; 2007 Dec; 15(12):2194-202. PubMed ID: 17968355
[TBL] [Abstract][Full Text] [Related]
20. Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation.
Takahashi K; Nagai N; Ogura K; Tsuneyama K; Saiki I; Irimura T; Hayakawa Y
Cancer Sci; 2015 Jul; 106(7):867-74. PubMed ID: 25940224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
